Jiangjie blood supplementing mixture and its application

Abstract

The invention relates to a Jiangjie Buxue Mixture (used name: Sanyangxuedai) and its application, belonging to the field of traditional Chinese medicine anticancer drugs. Jiangjie blood-replenishing mixture of the present invention (formerly used name: Sanyangxue Dai Guoyao Zhunzi Z20025065) consists of ginger 100g, dragon's blood 10g, yam 132g, Poria 60g, amomum 17g, angelica 25g, notoginseng 10g, licorice 45g, 833g of rice wine is made into a mixture of 1000ml after soaking, heating, filtering, concentrating, sterilizing and filling according to the existing preparation method. The invention can antagonize the toxic and side effects of cancer patients during radiotherapy and chemotherapy, improve the sensitivity of radiotherapy and chemotherapy, improve the quality of life of cancer patients, prolong the survival period of patients, and can be used as an auxiliary drug for cancer radiotherapy and chemotherapy. It has the advantages of being superior to similar drugs at home and abroad in various indicators, convenient to take, and remarkable curative effect.

Description

Field of invention: [0001] The invention relates to a ginger and scorpion blood-enriching mixture (used name: Sanyangxuedai) and its application, belonging to the field of traditional Chinese medicine anticancer drugs. Background technique: [0002] According to statistics from the World Health Organization (WHO) and the International Union Against Cancer, there are currently about 40 million cancer patients worldwide, with 10 million new patients each year, and an average of 27,300 people suffer from cancer every day. By 2020, the global cancer incidence rate will increase by 50% compared with the present, with up to 15 million new patients each year. [0003] According to the International Cancer Research Center of the World Health Organization in Lyon, France, with the increasingly serious environmental pollution, the arrival of an aging society, and fierce market competition, people's physical and psychological stress will increase, and immune function will decline. Yea...

AI Technical Summary

Problems solved by technology

But so far, whether it is genetically modified drugs, botanical drugs, chemically synthesized drugs, biological agents, etc., such adjuvant drugs for radiotherapy and chemotherapy developed by large western pharmaceutical companies often have single effects, large side effects, and high prices.

For example, the transgenic drug "recombinant human granulocyte colony-stimulating factor" (trade name: G-CSF; produced in Japan: Wheel blood) developed by Amgen Corporation of the United States (AMGEN) is only effective for neutrophils (white blood cells), but not for red blood cells. It is ineffective with platelets, long-term use will also lead to exhaustion of bone marrow hematopoietic function, affecting the regeneration of whole blood cells

Patients generally use 2-3 courses of G-CSF preparations, and there is no obvious curative effect

However, the domestically produced G-CSF-like whitening drugs are all imitations of foreign "recombinant human granulocyte colony stimulating factor", and their curative effect is not as good as that of foreign drugs.

[0006] The inventor has inquired about the traditional Chinese medicine literature of the Ministry of Health in the past 3 years. Except for Jiangjie Buxue Mixture (former name: Sanyangxuedai), there is no pharmacodynamics and clinical comparison with Huier blood imported from Japan. Reports on proprietary Chinese medicines

Images